⏳ Fetching live dividend data...
Home › Calculator › AZNCF Dividend Calculator 2026
AstraZeneca PLC · OTC
Price: $189.90 · Annual div: $2.63/share · Frequency: semi-annual · Payout ratio: 40% · Ex-div: 2026-08-07
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-08-07Latest | 2026-09-08 | $1.0600 | — | — |
| 2026-02-20 | 2026-03-23 | $2.1700 | 2.55% | $188.41 |
| 2025-08-08 | 2025-09-08 | $0.5150 | 2.45% | $147.50 |
| 2025-02-21 | 2025-03-24 | $2.1150 | 2.18% | $141.90 |
| 2024-08-09 | 2024-09-09 | $0.9850 | 1.84% | $160.60 |
| 2024-02-22 | 2024-03-25 | $1.9710 | 3.67% | $132.12 |
| 2023-08-10 | 2023-09-11 | $0.9130 | 2.67% | $142.85 |
| 2023-02-23 | 2023-03-27 | $1.9610 | 3.81% | $127.46 |
| 2022-08-11 | 2022-09-12 | $0.9330 | 2.86% | $132.64 |
| 2022-02-24 | 2022-03-28 | $1.9680 | 4.13% | $116.50 |
| 2021-08-12 | 2021-09-13 | $0.8990 | 3.25% | $115.33 |
| 2021-02-25 | 2021-03-29 | $1.9430 | 4.72% | $100.48 |
| 2020-08-13 | 2020-09-14 | $0.9070 | — | — |
| 2020-02-27 | 2020-03-30 | $1.8890 | — | — |
| 2019-08-08 | 2019-09-09 | $0.8730 | — | — |
| 2019-02-28 | 2019-03-27 | $1.9540 | — | — |
| 2018-08-09 | 2018-09-10 | $0.8810 | — | — |
| 2018-02-15 | 2018-03-19 | $1.8700 | — | — |
| 2017-08-10 | 2017-09-11 | $0.8960 | — | — |
| 2017-02-16 | 2017-03-20 | $1.8720 | — | — |
| 2016-08-11 | 2016-09-12 | $0.8903 | — | — |
| 2016-02-18 | 2016-03-21 | $2.0810 | — | — |
| 2015-08-13 | 2015-09-14 | $0.9970 | — | — |
| 2015-02-19 | 2015-03-23 | $2.1440 | — | — |
| 2014-08-13 | 2014-09-15 | $0.9920 | — | — |
| 2014-02-19 | 2014-03-24 | $2.1110 | — | — |
| 2013-08-14 | 2013-09-16 | $0.9194 | — | — |
| 2013-02-13 | 2013-03-18 | $2.1111 | — | — |
| 2012-08-08 | 2012-09-10 | $0.9097 | — | — |
| 2012-02-15 | — | $2.1667 | — | — |
| 2011-08-03 | — | $0.9444 | — | — |
| 2011-02-02 | — | $2.0556 | — | — |
| 2010-08-04 | — | $0.7778 | — | — |
| 2010-02-03 | — | $1.9000 | — | — |
| 2009-08-05 | — | $0.6556 | — | — |
AstraZeneca PLC functions as a global biopharmaceutical enterprise, committed to the entire process of pharmaceutical innovation, spanning from the initial discovery and development stages to the manufacturing and market introduction of its prescription medications. The company boasts a comprehensive portfolio of drugs addressing a diverse array of therapeutic areas. This encompasses a robust selection for oncology, featuring key treatments such as Calquence, Enhertu, and Tagrisso, alongside vital therapies for cardiovascular, renal, and metabolic conditions, including Farxiga/Forxiga and Brilinta/Brilique. Its offerings further extend to impactful medications for respiratory and immunological ailments like Symbicort and Fasenra, as well as specialized remedies for rare diseases, notably Soliris and Ultomiris. Beyond these primary categories, AstraZeneca's product range includes solutions for infectious diseases, such as Synagis for RSV and the COVID-19 vaccines Vaxzevria and Evusheld, in addition to treatments for neurological disorders like Seroquel and gastrointestinal issues epitomized by Nexium. AstraZeneca distributes its pharmaceuticals to medical practitioners in both primary and specialty care settings worldwide, utilizing an extensive network of distributors and local offices throughout the United Kingdom, the rest of Europe, the Americas, Asia, Africa, and Australasia. The company actively engages in strategic alliances to propel its research and development efforts. Significant collaborations include agreements with Regeneron Pharmaceuticals, Inc., for the creation of small molecule medicines targeting obesity; Neurimmune AG, for developing and commercializing NI006; Ionis Pharmaceuticals, Inc., to advance eplontersen, a liver-targeted antisense therapy in Phase III development for transthyretin amyloidosis; Proteros Biostructures GmbH, for co-discovering novel small molecules for hematological cancers; and Sierra Oncology, Inc., regarding the development and commercialization of AZD5153. Founded in 1992, the company, formerly known as Zeneca Group PLC, rebranded as AstraZeneca PLC in April 1999 and is headquartered in Cambridge, United Kingdom.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AZNCF position with:
Real after-tax yield depends on where you live and how you hold AZNCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.38% | -1.42% | $138 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.17% | -1.63% | $117 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.10% | -1.70% | $110 / yr |
| 🇬🇧 UK ISA | 0% | 1.38% | -1.42% | $138 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.26% | -1.54% | $126 / yr |
| 🇨🇦 TFSA | 0% | 1.38% | -1.42% | $138 / yr |
| 🇨🇦 CA Taxable | 25% | 1.03% | -1.76% | $104 / yr |
| 🇦🇺 Super (pension) | 15% | 1.17% | -1.63% | $117 / yr |
| 🇦🇺 AU Taxable | 30% | 0.97% | -1.83% | $97 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.02% | -1.78% | $102 / yr |
| 🇫🇷 FR Taxable | 30% | 0.97% | -1.83% | $97 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.63/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
AZNCF pays quarterly — 4 times per year. Ex-div: 2026-08-07.
How AZNCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AZNCF sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare AZNCF with peers: AZNCF vs CHGCF · AZNCF vs CHGCY · AZNCF vs FSNUY
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AZNCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
AstraZeneca PLC (AZNCF) is currently trading at $189.90, 9% below its 52-week high. The current dividend yield is 1.38% based on an annual payout of $2.63 per share.
AstraZeneca PLC (AZNCF) is a healthcare stock currently trading at $189.90 with a dividend yield of 1.38%. It pays an annual dividend of $2.63 per share. The payout ratio of 40% suggests the dividend is well-covered by earnings. Over the past 5 years, AZNCF has grown its dividend at a compound annual rate of 2.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.
AZNCF (AstraZeneca PLC) has a dividend yield of 1.38%, based on an annual dividend of $2.63 per share and a price of $189.90. Over the last 12 months it paid $3.23 per share — a trailing yield of 1.70%. Dividends are paid semi-annual.
Yield history: over the last 11 payments, AZNCF's 12-month yield ranged from 1.84% to 4.72%. Full AZNCF dividend history ↓
Yield on cost: if AZNCF's dividend keeps growing 2.0% a year, a purchase at today's price would yield 1.53% after 5 years, 1.69% after 10 years and 2.06% after 20 years on the original investment.
With dividends reinvested, a AZNCF position grows its share count by about 1.24% in the first year at today's price and yield.
| Year | Shares bought by dividends | Total shares | Dividend income | Position value | Yield on cost |
|---|---|---|---|---|---|
| 1 | 0.66 | 53.31 | $141 | $11,491 | 1.41% |
| 3 | 0.54 | 54.45 | $150 | $15,119 | 1.50% |
| 5 | 0.45 | 55.39 | $160 | $19,813 | 1.60% |
| 10 | 0.27 | 57.06 | $182 | $38,444 | 1.82% |
| 20 | 0.10 | 58.66 | $229 | $140,215 | 2.29% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work →
AZNCF (AstraZeneca PLC) has a dividend yield of 1.38%, based on an annual dividend of $2.63 per share and a price of $189.90. Over the last 12 months it paid $3.23 per share — a trailing yield of 1.70%. Dividends are paid semi-annual.
$10,000 in AZNCF at a 1.38% yield pays about $138 a year ($12 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a AZNCF position grows its share count by about 1.24% in the first year at today's price and yield.
Enter your starting amount, monthly contribution and time horizon in the AZNCF DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
AZNCF's next ex-dividend date has not been announced yet; the most recent one was 2026-08-07. AZNCF pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
AZNCF's dividend changed 22.8% over the last year and 2.0% a year on average over five years.
AZNCF pays out 40% of its earnings as dividends. A payout ratio under 60% is generally considered sustainable. Dividends can be cut at any time; this is not financial advice.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever